Treatment with GLP-1 RAs has been associated with improved insulin sensitivity, as reflected by reductions in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) scores, and these changes often align with improvements in psoriasis severity
Additionally, a comparison group received synthetic Exe4 peptide via a subcutaneously implanted osmotic pump (Peptide), releasing Exe4 peptide into the host circulatory system and then removed at 8 weeks after initial implantation to simulate treatment interruption
R-Alpha-Lipoic Acid (R-ALA)
Targeted GLP-1 receptor agonist therapy for weight reduction or type 2 diabetes mellitus has shown substantial improvement in symptoms of AUD
Another toxin produced by GAS is streptococcal pyrogenic exotoxin B (SpeB)
All were small short-term studies, currently recommended Hb levels were not achieved, and in 2 of the studies, the ESA doses used were lower than those used in most patients with HD-CKD on chronic ESA treatment